- Home
- PRME vs SLDP Comparison
PRME vs SLDP Comparison
Compare PRME & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- SLDP
- Stock Information
- Founded
- PRME 2019
- SLDP 2011
- Country
- PRME United States
- SLDP United States
- Employees
- PRME N/A
- SLDP N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- SLDP Electrical Products
- Sector
- PRME Health Care
- SLDP Energy
- Exchange
- PRME Nasdaq
- SLDP Nasdaq
- Market Cap
- PRME 693.5M
- SLDP 645.4M
- IPO Year
- PRME 2022
- SLDP N/A
- Fundamental
- Price
- PRME $4.67
- SLDP $3.74
- Analyst Decision
- PRME Buy
- SLDP Buy
- Analyst Count
- PRME 6
- SLDP 2
- Target Price
- PRME $8.88
- SLDP $2.50
- AVG Volume (30 Days)
- PRME 2.9M
- SLDP 8.2M
- Earning Date
- PRME 11-11-2025
- SLDP 11-06-2025
- Dividend Yield
- PRME N/A
- SLDP N/A
- EPS Growth
- PRME N/A
- SLDP N/A
- EPS
- PRME N/A
- SLDP N/A
- Revenue
- PRME $4,961,000.00
- SLDP $22,667,000.00
- Revenue This Year
- PRME $179.58
- SLDP $28.39
- Revenue Next Year
- PRME N/A
- SLDP $38.07
- P/E Ratio
- PRME N/A
- SLDP N/A
- Revenue Growth
- PRME 739.42
- SLDP 14.83
- 52 Week Low
- PRME $1.11
- SLDP $0.68
- 52 Week High
- PRME $5.17
- SLDP $5.62
- Technical
- Relative Strength Index (RSI)
- PRME 67.60
- SLDP 45.86
- Support Level
- PRME $3.09
- SLDP $3.53
- Resistance Level
- PRME $4.18
- SLDP $4.02
- Average True Range (ATR)
- PRME 0.31
- SLDP 0.33
- MACD
- PRME 0.11
- SLDP -0.09
- Stochastic Oscillator
- PRME 98.14
- SLDP 17.50
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About SLDP Solid Power Inc.
Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.